Evaluating the state of the science for adeno-associated virus integration: An integrated perspective
2022 · Molecular Therapy · 180 citations
https://doi.org/10.1016/j.ymthe.2022.06.004
D
Douglas M. McCarty
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
4.9K
Citations
35
h-index
49
i10-index
Douglas M. McCarty is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Virus-based gene therapy research & Lysosomal Storage Disorders Research & RNA Interference and Gene Delivery. The author has an h-index of 35, co-authored 72 publications.
Papers by this author
worksPatterns of scAAV Vector Insertion Associated With Oncogenic Events in a Mouse Model for Genotoxicity
2012 · Molecular Therapy · 97 citations
https://doi.org/10.1038/mt.2012.197
Oligodendrocyte-specific gene expression in mouse brain: Use of a myelin-forming cell type-specific promoter in an adeno-associated virus
1999 · Journal of Neuroscience Research · 70 citations
https://doi.org/10.1002/(sici)1097-4547(19990215)55:4<504::aid-jnr10>3.0.co;2-0
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery
2016 · Molecular Therapy — Methods & Clinical Development · 58 citations
https://doi.org/10.1038/mtm.2016.36
A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design
2016 · Molecular Genetics and Metabolism · 50 citations
https://doi.org/10.1016/j.ymgme.2016.08.002
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response
2010 · Journal of Neuroinflammation · 39 citations
https://doi.org/10.1186/1742-2094-7-39
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat